eli lilly's tirzepatide is the leader in weight loss sector weight-loss drug reduces sleep apnea severity late-stage trials Eli Lilly cracks down on

Potential treatment effect modifiers were also accounted for in the primary analysis by restricting the SURPASS2 population to patients complying with the HbA1c inclusion criterion of SUSTAIN FORTE (referred to as the SURPASS2 refined population)

Furthermore, the trim and fill model did not identify any missing studies, corroborating the robustness of the findings

This dual mechanism reduces appetite, improves insulin sensitivity, and enhances fat loss

To better understand tirzepatides psychiatric safety, population-level studies and dedicated trials are needed

Semaglutide is a prescription medication approved by the FDA to help manage type 2 diabetes (Ozempic) and to support long-term weight loss (Wegovy)

netmeta: an R Package for network meta-analysis using frequentist methods